FILE PHOTO: A medical worker prepares to administer a vaccination against the coronavirus disease (COVID-19) in a neighbourhood with a high residency of foreign nationals, including migrant workers, in Tel Aviv, Israel February 9, 2021. REUTERS/Amir Cohen/File Photo
JERUSALEM (Reuters) - Israel’s swift vaccination rollout has made it the largest real-world study of Pfizer Inc's COVID-19 vaccine. Results are trickling in, and they are promising.
More than half of eligible Israelis - about 3.5 million people - have now been fully or partially vaccinated. Older and at-risk groups, the first to be inoculated, are seeing a dramatic drop in illnesses.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
